Thomas Flaig, University of Colorado Anschutz Medical Campus (IMAGE)

University of Colorado Anschutz

Thomas Flaig, University of Colorado Anschutz Medical Campus

Caption

Thomas Flaig, MD, and colleagues show that COXEN may predict which patients will respond to chemotherapy before bladder cancer surgery

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.